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Background:  Increased  levels  of  homocysteine  and  oxidized  low-density  lipoprotein  (Ox-LDL)  are consid-
ered independent  risk  factors for atherosclerosis.  However,  no  previous  study  has examined  the  effects  of
ethanol-induced  increase  of homocysteine  and  Ox-LD  on aortic  vascular  smooth  muscle  cell (VSMC)  pro-
liferation.  The  aim  of the  present  study  was  to investigate  the  relationship  between  ethanol  consumption,
increase  in  homocysteine,  Ox-LDL,  and  aortic  VSMC  proliferation  in rats.
Methods  and  results:  To  address  this  issue,  24  male Wistar  rats  were  randomly  divided  into  three  groups:
control,  sham,  and  ethanol-treated.  Homocysteine,  Ox-LDL,  lipid proﬁle,  and  aortic  VSMC  proliferationxidized-low-density lipoprotein
ascular smooth muscle cell
omocysteine
at
were  assessed  after  42  days.  The  results  revealed  a concurrent,  signiﬁcant  increase  in homocysteine  and
Ox-LDL  levels,  lipid  proﬁle  levels,  and aortic  VSMC  proliferation  in  the  ethanol-treated  group  compared
with  the  control  and  sham  groups.
Conclusion:  Based  on these  results,  we  conclude  that  ethanol  apparently  exerts  aortic  VSMC  prolifer-
 hom
n the
3  Japation  through  increase  in
proatherogenic  changes  i
©  201
ntroduction
The relationship between ethanol consumption and cardiovas-
ular system function is ambiguous. Some epidemiologic studies
ave demonstrated that moderate amounts of ethanol may  reduce
ardiovascular risk by reducing blood pressure and suppressing
mooth muscle cell proliferation [1,2]. Despite these beneﬁ-
ial effects, some studies have found that ethanol consumption
ncreased the risk of hypertension and the risk of cardiovascu-
ar disease with progression of atherosclerosis [3,4]. It seems
hat the effects of ethanol on the cardiovascular system depend
n various factors, including drinking patterns, dose, gender,
nd type of beverage. It is therefore evident that the effects of
thanol on the cardiovascular system are complex and identiﬁca-
ion of the underlying mechanisms that may  explain paradoxical
ffects of ethanol is highly warranted. Recently, we provided evi-
ence that ethanol consumption increases lipid peroxidation and
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ttp://dx.doi.org/10.1016/j.jjcc.2013.06.003ocysteine  and  Ox-LDL-mediated  oxidative  stress,  which  in turn  trigger
 aortic  wall.
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protein oxidation in the hippocampus and cerebellum of rats
[5,6]. A study conducted by Haorah et al. showed that ethanol
metabolism in the vascular system leads to oxidative stress and the
generation of reactive oxygen species (ROS) [7]. In addition, our
studies have shown that ethanol causes hyperhomocysteinemia,
which in turn may  lead to production of free radicals that induce
cardiovascular disorders [5]. The association between hyperhomo-
cysteinemia as an independent risk factor for atherosclerosis has
been reported in several studies [8–10], but the mechanism by
which hyperhomocysteinemia increases the risk for atherosclerosis
is not fully understood and it may  be caused by homocysteine-
induced release of superoxide anions (O•−) and hydrogen peroxide
(H2O2) [11]. In addition to hyperhomocysteinemia, hyperlipidemia
is an important independent risk factor for the development of
atherosclerosis in the cardiovascular system [12]. Hyperlipidemia
or hypercholesterolemia [more speciﬁcally, elevated low-density
lipoprotein (LDL) cholesterol] are accepted as important risk fac-
tors for the development of atherosclerosis in humans [13–16].
The oxidized form of LDL (Ox-LDL) is an important contribu-
tor to the initiation and progression of atherosclerosis because
of its cytotoxic and chemotactic properties [17,18]. Excess LDL
in the interstitium is taken up by monocyte macrophages and
is then subjected to an oxidation process that leads to the
vier Ltd. All rights reserved.
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ormation of Ox-LDL [18,19]. Ox-LDL has been shown to affect
ascular smooth muscle cell growth by inducing proliferation
r apoptosis [20]. There is some experimental evidence for the
ro-oxidant action of ethanol that has been attributed to LDL mod-
ﬁcation by acetaldehyde [21], to an alcohol-induced increase in
ADH-dependent ROS generation [22], and to the mobilization
f Fe2+ ions, thereby increasing lipid peroxidation [23]. The pro-
xidant effects of ethanol increase the oxidative susceptibility of
DL and thus may  diminish the antiatherosclerotic effects of mod-
rate alcohol consumption [24]. Thus, controversy surrounds the
ole of alcohol consumption in cardiovascular system functions,
nd the mechanisms that are triggered by these contrary actions
re still poorly understood. To clarify the various effects of ethanol,
e evaluated the effect of high-dose ethanol consumption on aortic
ascular smooth muscle cell proliferation and the possible mecha-
isms responsible for this activity in rat aortas.
aterials and methods
All experiments and procedures were performed in accordance
ith the Principles of Laboratory Animal Care (NIH publication
o. 85-23, revised 1985) as well as the speciﬁc rules provided
y the Animal Care and Use Committee, National Medical and
ealth Service. Twenty-four male Wistar rats (initial body weight
10 ± 10 g) were divided into three groups: control, sham, and
thanol-treated groups. Ethanol-treated rats received 4.5 g/kg BW
thanol (Merck KGaA, Darmstadt, Germany) solution in normal
aline (20%, w/v) intragastrically by gavage once per day for 6
eeks. The control group was treated with vehicle only (normal
aline). To rule out any effects of the intragastric gavage on the
easured parameters, the same number of rats was assigned to a
ham group, which received no intervention. Daily food and water
ere provided ad libitum for all animals throughout the experi-
ent. After 6 weeks, all rats were intraperitoneally anesthetized
ith ethyl carbamate (urethane) (1 mg/kg), and the depth of anes-
hesia was assessed by pinching a hind paw. The thoracic cavity
as opened, and blood samples were collected directly from the
eart by syringe. The samples were mixed with ethylene diamine
etra acetic acid (EDTA) as an anticoagulant, and centrifuged at
000 × g for 20 min. The plasma was then separated and stored at
20 ◦C until analysis without a repeated freeze–thaw cycle. After
he blood sample collection, the aorta was removed from the root
o the descending abdominal aorta. Adventitial tissue and fat was
emoved from the excised aorta, and half of the aorta was ﬁxed
nd embedded in parafﬁn after standard dehydration steps were
erformed. Another section of the aorta was washed with ice-cold
hysiological saline solution, dried and processed for biochemical
easurements. A 10% (w/v) homogenate was prepared in 50 mM
hosphate buffer (pH 7.4) and centrifuged at 10,000 × g for 20 min
t 4 ◦C in a refrigerated centrifuge. The supernatant was  collected
nd stored at −80 ◦C until analysis, without a repeated freeze–thaw
ycle. Homocysteine levels in the supernatant were measured by
eans of a high-pressure liquid chromatography method using
he ClinRep complete kit (Recipe Chemical and Instruments GmbH,
unich, Germany), according to the manufacturer’s instructions
fter removal of proteins by means of trichloroacetic acid (TCA).
he ﬂow rate was 1.0 ml/min, and the column temperature was
0 ◦C. The retention times obtained for cysteine, internal standard,
ysteinylglycine, and homocysteine were 2.07, 2.41, 2.76, and
.29 min, respectively. The ﬂuorescence detector was  set to 385 and
15 nm excitation and emission wave lengths, respectively. Twenty
illiliters of the sample or calibrator (ClinCal and ClinChek, Recipe
hemical and Instruments GmbH) was injected. The calculation
f unknown samples was performed using the internal standard
ethod via peak areas.iology 62 (2013) 374–378 375
Ox-LDL
Tissue Ox-LDL levels were measured using a capture enzyme-
linked immunosorbent assay (ELISA; also known as a “sandwich”
ELISA) kit, in which the wells of the microtiter plates were coated
with the capture antibody mAb-4E6 (Mercodia, Sweden). Diluted
supernatant samples (1:6561) were used for the ELISA measure-
ments. The optical density of the wells was read at 450 nm,  and the
results were calculated.
Lipid proﬁle
Serum triglyceride (TG) and total cholesterol were measured
by colorimetric and enzymatic methods, and serum LDL-C and
high-density lipoprotein cholesterol (HDL-C) were assayed by a
direct method using Biosystem kits (Biosystem, Barcelona, Spain).
Apolipoprotein (apo) A and apoB were measured by a nephelomet-
ric method using a Mono Binding kit (Binding Site, Birmingham,
UK), following the kit’s instructions.
Proliferating cell nuclear antigen staining
Tissue sections (4 m thick) from the formalin-ﬁxed parafﬁn-
embedded aorta were deparafﬁnized by immersing them in xylene,
rehydrating them by gradual ethanol passage, and washing them
in Tris buffer. Monoclonal rat anti-proliferating cell nuclear anti-
gen (PCNA) antibody (Dako Denmark A/S, Glostrup, Denmark) was
used to stain the slides after the appropriate Ag retrieval step,
and optimal results were achieved with the EnVisionTM visual-
ization system (Dako Denmark A/S). Hematoxylin was  used as a
counterstain. Appropriate negative controls were included in the
assessment, and all slides were independently inspected by two
expert pathologists. PCNA-positive indices were considered as indi-
cators of proliferation of muscle cells. Scoring was performed in the
following fashion:
One hundred cells were scored from each tissue section for
assessing the percentage of PCNA-positive indices. The criteria for
quality scoring of PCNA-positive indices were as follows: normal,
PCNA-positive indices less than 5%; mild, PCNA-positive indices
present in less than 25% of muscle cells; mild to moderate, PCNA-
positive indices present in 25% to 50% of muscle cells; moderate
to severe, PCNA-positive indices present in 50% to 75% of muscle
cells; severe, PCNA-positive indices present in 75% to 100% of mus-
cle cells. The sections were examined under light microscope, and
photomicrographs were taken.
Statistical analysis
Statistical signiﬁcance between the groups was assessed by one-
way ANOVA, followed by Tukey’s post hoc test. In each test, the
data are expressed as the mean ± S.E.M. and p < 0.05 was accepted
as statistically signiﬁcant.
Results
Table 1 shows the effects of ethanol consumption on the lipid
proﬁle. TG levels were signiﬁcantly higher in the ethanol-treated
animals compared with the levels in the control and sham groups
(p < 0.05). TG levels did not differ between the control and sham
groups. The cholesterol levels were similar between the control and
sham groups. Total cholesterol levels were signiﬁcantly increased
in the ethanol-treated group compared with the levels in the con-
trol and sham groups (p < 0.005). LDL levels were signiﬁcantly
increased in the ethanol-treated group compared with the levels
in the control and sham groups (p < 0.05). There were no signiﬁcant
differences between the sham and control groups in terms of LDL
376 A. Shirpoor et al. / Journal of Cardiology 62 (2013) 374–378
Table 1
Serum lipid proﬁle in different groups of rats.
Biochemical analyte Control Sham Ethanol treated
Triglyceride (mg/dl) 32.85 ± 1.42 29.85 ± .9 52 ± 3*
Cholesterol (mg/dl) 48.8 ± 1.98 48.4 ± 2.6 63 ± 2.5*
LDL (mg/dl) 27.71 ± 1.47 25.71 ± 2.3 34.5 ± 1.8*
HDL (mg/dl) 31.57 ± 1.68 30.71 ± 2.2 40.87 ± 2.23*
Apo-A (mg/l) 138.5 ± 4.5 143 ± 8.2 77 ± 3.2*
Apo-B (mg/l) 118.7 ± 3.5 112 ± 2.24 176 ± 4.6*
Apo-B/apo-A .86 ± .04 .8 ± .04 2.31 ± .1*
HDL/TG 1.01 ± .06 1.03 ± .07 .8 ± .06*
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Fig. 1. Levels of Ox-LDL and Hcy contents in aorta tissue of different groups; Ox-LDL
(a) and Hcy (b) contents of aorta tissue in ethanol-treated group of rats were sig-
niﬁcantly higher than in control and sham groups. Values are means ± SE, p < 0.05.
Hcy, homocysteine; Ox-LDL, oxidized low-density lipoprotein. *Signiﬁcant differ-
ence compared to control and sham.alues expressed as mean ± S.E.M., p < 0.05.
* Signiﬁcant difference compared to control and sham.
evels. Changes in the HDL levels among the three groups mirrored
hose of the LDL levels mentioned above. ApoA levels were signif-
cantly decreased in the ethanol-treated group compared with the
evels in the sham and control groups (p < 0.005), but there were no
igniﬁcant differences between the sham and control groups. There
ere signiﬁcant increases in apoB levels in the ethanol-treated
roup compared with the levels in the sham and control groups
p < 0.005). The apoB levels were similar between the sham and
ontrol groups. The apoB/apoA ratio showed a signiﬁcant increase
n the ethanol-treated group compared with the ratio in the control
nd sham groups (p < 0.005). There were no signiﬁcant differences
etween the control and sham group in terms of the apoA/apoB
atio. In the ethanol-treated group, the HDL/TG ratio was  signiﬁ-
antly lower than in the control and sham groups (p < 0.005), but
here were no signiﬁcant differences between the sham and control
roups.
Aortic Ox-LDL levels in the ethanol-treated group (65 ± 5.1 U/I)
ere signiﬁcantly higher than those in the control (21.85 ± 1.7 U/I)
nd sham (16 ± 0.87 U/I) groups (p < 0.005), but there were no sig-
iﬁcant differences between the sham and control groups (Fig. 1a).
The concentrations of aortic tissue homocysteine levels were
.1 ± 0.16 mg/l, 0.93 ± 0.14 mg/l, and 2.7 ± 0.21 mg/l in the control,
ham, and ethanol-treated groups, respectively. Tissue homocys-
eine levels were signiﬁcantly increased in the ethanol treated
roup compared with the levels in the control and sham groups
p < 0.005). No signiﬁcant changes were found between the control
nd sham groups (Fig. 1b). The ratio of proliferated cells (PCNA-
ositive indices) in the aortas of control, sham, and ethanol-treated
ats (2 ± 1%, 3%, and 31 ± 3%, respectively) are shown in Fig. 2. The
CNA-positive indices (as indicators of proliferation) were dramat-
cally increased in the ethanol-treated group compared with the
ndices in the control and sham groups (p < 0.005). There were no
igniﬁcant differences between the control and sham groups.
iscussion
We  observed increased levels of various serum lipids, such as
holesterol, TG, LDL, and apoB and a simultaneous decrease in apoA
evels, after ethanol intake. An immunohistopathological examina-
ion demonstrated a dramatic increase in PCNA-positive indices in
he ethanol-treated group as an indicator of vascular smooth mus-
le cell proliferation. The results of this study showed signiﬁcantly
ncreased levels of homocysteine and Ox-LDL in the aortic tissue
f the ethanol-treated rats. Our results also show an association
etween homocysteine and Ox-LDL and vascular smooth mus-
le cell proliferation, whose physiopathological mechanisms are
nknown. It has been suggested that oxidative stress plays a central
ole in the pathogenesis of many ethanol-related disorders. Human
nd animal studies have reported increased oxidative stress in var-
ous ethanol-induced organ disorders [6,25]. To our knowledge,
o study has yet investigated the role of the association between
ascular smooth muscle cell proliferation and the homocysteine
Fig. 2. Photomicrographs showing proliferating cell nuclear antigen-positive cell
expression in aorta of different groups (magniﬁcation 400×). (a) Sham. (b) Control.
(c)  Ethanol.
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nd Ox-LDL levels induced by heavy ethanol consumption in rats.
ome studies have demonstrated that homocysteine may  provoke
mooth muscle cell growth and result in accelerated atheroscle-
osis [26,27]. Although studies have documented measures of
he homocysteine-mediated alteration in vascular smooth muscle
ells, the underlying mechanism is not fully understood. There is
bundant evidence from previous studies that suggests that homo-
ysteine may  exert its effects on blood vessel function abnormality
hrough multiple factors. Homocysteine increases lipid peroxida-
ion, protein oxidation, and alters the antioxidant defense system
28]. Homocysteine increases hydrogen peroxide and superoxide
nion levels through disulﬁde formation and thereby increases
xidative degradation of NO [29,30]. Impaired NO induction is a
redictor of vascular morbidity and mortality and impairs endothe-
ial vasodilator function [30,31]. A recent study conducted by Liu
t al. revealed that homocysteine incubation with vascular smooth
uscle cells induces signiﬁcant proliferation of vascular smooth
uscle cells along with signiﬁcantly increased expression of pro-
eins, such as glycolytic metabolism proteins (PKM2, TPI, and AR),
ytoskeletal proteins (lamin C and vitamins), and other proteins
uch as calreticulin, WDR1, and SH3 [32]. Other studies have
hown that homocysteine induces the expression of proteins such
s the heat-shock protein 27, CapZ, tumor necrosis factor-a, and
ytoskeleton elements [33–35]. These proteins are known as pro-
oter proteins for vascular smooth muscle cell proliferation and
rowth. Growth and proliferation of vascular smooth muscle cells
re considered to be key events in the pathogenesis of atheroscle-
osis. In the current study, the signiﬁcant increase in homocysteine
evels paralleled aortic smooth muscle cell proliferation. This may
e strong evidence suggesting that ethanol induces its atheroscle-
otic effect on the vascular structure through homocysteine. It has
lso been reported that homocysteine increases transcription of
-hydroxy-3-methyl-glutaryl (HMG)-coenzyme A (CoA) reductase
nd the activity of HMG-CoA reductase in the liver and conse-
uently signiﬁcantly increases cholesterol and TG levels in rat
erum [36]. In the current study, cholesterol, TG, LDL, and apoB lev-
ls were signiﬁcantly increased in the ethanol-treated group when
ompared with the levels in the control group. This increase in the
ipid levels may  have originated due to ethanol-induced increase of
omocysteine. It is well established that higher total serum choles-
erol and LDL levels are associated with increased cardiovascular
isease risk and mortality, and these simple markers are widely
ccepted as markers for disease risk [37]. Numerous research
tudies have conﬁrmed that hypercholesterolemia induces the pro-
uction of ROS, such as superoxide anions, through enzymes such
s NADPH oxidase and xanthine oxidase as well as through other
itochondrial ROS sources [38,39]. Elevated serum triglycerides,
s observed in the ethanol-treated group, are a risk factor for
ardiovascular complications [40]. The current study showed a sig-
iﬁcant decrease in the HDL/TG ratio in the ethanol-treated group
hen compared with the ratio in the control and sham groups.
he HDL/TG ratio provides information on LDL composition, size,
nd density. A diminished HDL/TG ratio in ethanol-treated group
ndicated lower size of LDL cholesterol, and small LDL choles-
erol is more susceptible to oxidative modiﬁcation [40]. The apoA
nd apoB levels in the ethanol-treated group were signiﬁcantly
ifferent from those in the control group; apoA levels were signif-
cantly decreased and apoB levels were signiﬁcantly increased in
he ethanol-treated group when compared with those in the con-
rol and sham groups. ApoA and apoB serve as proteins for the very
ow-density lipoprotein spectrum (LDL, VLDL, and lipoprotein) and
DL, and they determine the metabolic fate of these lipoproteins
41]. In general, apoB-containing lipoproteins carry lipids from the
iver and gut to sites that use the lipids, whereas apoA-containing
articles mediate reverse cholesterol transport and bring excess
holesterol from peripheral tissues to the liver [41]. As discussed byiology 62 (2013) 374–378 377
Walldius and Jungner [42], there are advantages in measuring apoB
and apoA [42]. Their concentrations reﬂect the particle numbers of
their respective lipoprotein classes and thus the opposite aspects
of risks [42]. A high apoB/apoA ratio indicates a high number of
atherogenic lipoprotein particles that are likely to be deposited in
the arterial wall [42]. Our study showed a dramatic increase in apoB
levels and in the apoB/apoA ratio, along with vascular endothelial
proliferation in the ethanol-treated group, changes that may favor
the deposition of lipids in the arteries and the consequent arterial
complications.
Another important ﬁnding of this study was  the signiﬁcant
increase in Ox-LDL levels in the ethanol-treated group when com-
pared to the levels in the control and sham groups. The role of
Ox-LDL has recently been demonstrated in the pathogenesis of
atherosclerosis. Ox-LDL promotes atherosclerosis by not only pro-
viding lipid signals that initially activate macrophages but also by
stimulating foam cell formation [43]. In addition, Ox-LDL stimulates
the generation of ROS [44]. The mitogenic effect of LDL particles
(native or oxidized) on smooth muscle cells has been reported [45].
Moreover, Ox-LDL is able to induce smooth muscle cell prolifer-
ation by generating phospholipase D-related second messengers
that modulate mutagenesis [46]. Ox-LDL particles have also been
shown to increase apoptosis of vascular endothelial cells, thereby
inﬂuencing the pathogenesis of atherosclerosis [47]. The present
study showed a positive association between ethanol consumption,
homocysteine, and Ox-LDL elevation, and vascular smooth mus-
cle cell proliferation. In line with this study, a previous publication
indicated a potential pathogenic role of Ox-LDL in cardiovascular
disease [48].
In conclusion, the current study brings new insights into alco-
hol consumption, because increases in intracellular homocysteine
and ox-LDL were associated with vascular smooth muscle cell pro-
liferation. Vascular smooth muscle cell proliferation suggests that
ethanol may  exert its proliferative effect through homocysteine and
Ox-LDL and result in oxidative stress due to these substances. How-
ever, further research is required to elucidate the ambiguous effect
of ethanol consumption on the cardiovascular system.
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